{"id":"W2095704084","doi":"10.1056/nejmoa1111097","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":469,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Docetaxel; Capecitabine; Medicine; Gemcitabine; Bevacizumab; Chemotherapy; Internal medicine; Cyclophosphamide; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004225351,0.0001444151,0.0005124761,0.0001570695,0.00003414577,0.000002883375,0.00007278888,0.00005185493,0.002537746],"category_scores_gemma":[0.00004535252,0.00008691132,0.00009536814,0.0001307088,0.00003435063,0.00007158509,0.000007341397,0.000162605,0.000005786656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001431552,"about_ca_system_score_gemma":0.0002076801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001165397,"about_ca_topic_score_gemma":0.00002775444,"domain_scores_codex":[0.9989894,0.00002483354,0.0003508924,0.00008706244,0.000251341,0.0002964493],"domain_scores_gemma":[0.9987303,0.0001286762,0.0001742479,0.00009521534,0.000198071,0.0006734654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01049902,0.0002494655,0.016451,0.00004588259,0.0004295545,0.0000320486,0.002829248,0.000006010101,0.02485878,0.00004373702,0.2304212,0.714134],"study_design_scores_gemma":[0.1767059,0.004276017,0.06507036,0.0004131757,0.0009274955,0.003286101,0.0001396423,0.00001183314,0.004350811,0.00009836685,0.7445841,0.0001362139],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7747101,0.0112522,0.001102699,0.2072242,0.003951319,0.0007215944,0.0000404391,0.0000217138,0.0009756475],"genre_scores_gemma":[0.9602123,0.001001545,0.0009381917,0.007814696,0.02769666,0.00001240018,0.000005992853,0.00002619793,0.00229201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7139978,"threshold_uncertainty_score":0.998374,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02998680873924625,"score_gpt":0.3709373581257419,"score_spread":0.3409505493864956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}